Pelthos Therapeutics Inc.
PTHS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $6,934 | $6,806 | $6,806 | $6,806 |
| - Cash | $513 | $96 | $55 | $0 |
| + Debt | $2,186 | $1,269 | $540 | $0 |
| Enterprise Value | $8,607 | $7,978 | $7,291 | $6,806 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$7,169 | -$6,862 | -$2,318 | -$595 |
| % Margin | – | – | – | – |
| Net Income | -$7,955 | -$7,381 | -$2,459 | -$595 |
| % Margin | – | – | – | – |
| EPS Diluted | -13.54 | -12.8 | -4.26 | -1 |
| % Growth | -5.8% | -200.5% | -326% | – |
| Operating Cash Flow | -$5,792 | -$981 | -$1,567 | – |
| Capital Expenditures | $0 | $0 | $0 | – |
| Free Cash Flow | -$5,792 | -$981 | -$1,567 | – |